New therapeutic use of chondroitin sulphate

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/737 (2006.01) A61P 17/06 (2006.01)

Patent

CA 2533329

The present invention relates to the use of an alkaline or alkaline earth metal chondroitin sulphate, which comes from an enzymatic hydrolysis of animal cartilage, for the preparation of a medicament for the treatment or prevention of psoriasis with skin affection in a mammal. Preferably the sodium chondroitin sulphate has an average molecular weight between 10,000 and 20,000 daltons, and is administered orally.

L'invention concerne l'utilisation du sulfate de chondroïtine de métal alcalin ou alcalino-terreux, issu de l'hydrolyse enzymatique de cartilage animal, pour l'élaboration de médicament utilisé dans le traitement ou la prévention du psoriasis avec affection de la peau chez un mammifère. De préférence, le sulfate de chondroïtine a une masse moléculaire moyenne comprise entre 10 000 et 20 000 daltons, et il est administré par voie orale.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

New therapeutic use of chondroitin sulphate does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with New therapeutic use of chondroitin sulphate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and New therapeutic use of chondroitin sulphate will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1428550

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.